Abstract
Purpose
The purpose was to determine the effects of recurrent breast cancer on health-related quality of life (HRQOL).
Methods
We administered the European Organization for Research and Treatment of Cancer (EORTC) QLQ-C30 and QLQ-BR23, McGill Quality of Life Questionnaire (MQOL), Beck Depression Inventory (BDI), and Brief Fatigue Inventory (BFI) to 152 women experiencing recurrence 1 year after being diagnosed with stage I to III breast cancer. We classified recurrent women as post-, ongoing-, and non-treatment group and performed multivariate-adjusted analyses in HRQOL comparisons with data available from disease-free survivors and general population.
Results
Groups not completing treatment were more symptomatic and had poorer functioning in HRQOL than the post-treatment group. Compared to the general population, the post-treatment group showed worse scores concerning role, cognitive, and social functioning, fatigue, and financial difficulties. The post-treatment group showed identical scores to disease-free survivors in most HRQOL domains; however, they reported less fatigue and depression than the disease-free group. Higher overall QOL was related to absence of comorbidity, completing treatment, being involved in decision making, no problems before surgery, and good overall medical care.
Conclusion
Treatment completed, most degraded aspects of HRQOL in recurrent breast cancer women can return to levels observed in disease-free survivors.
Similar content being viewed by others
References
Ahn, S. H., Park, B. W., & Noh, D. Y. et al. (2006, in press). Health-related quality of life in disease-free survivors of breast cancer with the general population. Annals of Oncology, 18.
Arndt, V., Merx, H., Stegmaier, C., Ziegler, H., & Brenner, H. (2005). Persistence of restrictions in quality of life from the first to the third year after diagnosis in women with breast cancer. Journal of Clinical Oncology, 23, 4945–953.
Ayanian, J. Z., Chrischilles, E. A., & Fletcher, R. H. et al. (2004). Understanding cancer treatment and outcomes: The Cancer Care Outcomes Research and Surveillance Consortium. Journal of Clinical Oncology, 22, 2992–996.
Beck, A. T. (1996). The Beck Depression Inventory. In I. McDowell & C. Newell (Eds.), Measuring health: A guide to rating scales and questionnaires (pp. 242–49). New York: Oxford University Press.
Bull, A. A., Meyerowitz, B. E., Hart, S., Mosconi, P., Apolone, G., & Liberati, A. (1999). Quality of life in women with recurrent breast cancer. Breast Cancer Research and Treatment, 54, 47–7.
Camilleri-Brennan, J., & Steele, R. J. (2001). The impact of recurrent rectal cancer on quality of life. European Journal of Surgical Oncology, 27, 349–53.
Cella, D. F., Mahon, S. M., & Donovan, M. I. (1990). Cancer recurrence as a traumatic event. Behavioral Medicine, 16, 15–2.
Cleary, P. D., & Edgman-Levitan, S. (1997). Health care quality. Incorporating consumer perspectives. JAMA, 278, 1608–612.
Cohen, S. R., Mount, B. M., Tomas, J. J., & Mount, L. F. (1996). Existential well-being is an important determinant of quality of life. Evidence from the McGill Quality of Life Questionnaire. Cancer, 77, 576–86.
Department of Health Care Policy Rockville, MD. (2003). Available from https://www.cahps-sun.org/Projects/ResultsForQI.asp#utility. Accessed November 4, 2005. (Author: This URL has been changed to https://www.cahps.ahrq.gov.).
Duric, V. M., Fallowfield, L. J., Saunders, C., Houghton, J., Coates, A. S., & Stockler, M. R. (2005). Patients–preferences for adjuvant endocrine therapy in early breast cancer: What makes it worthwhile?. British Journal of Cancer, 93, 1319–323.
Duric, V. M., Stockler, M. R., & Heritier, S. et al. (2005). Patients–preferences for adjuvant chemotherapy in early breast cancer: What makes AC and CMF worthwhile now?. Annals of Oncology, 16, 1786–794.
Efficace, F., Therasse, P., & Piccart, M. J. et al. (2004). Health-related quality of life parameters as prognostic factors in a nonmetastatic breast cancer population: An international multicenter study. Journal of Clinical Oncology, 22, 3381–388.
Ellman, R., & Thomas, B. A. (1995). Is psychological wellbeing impaired in long-term survivors of breast cancer? Journal of Medical Screening, 2, 5–.
Fayers, P. M. (2001). Interpreting quality of life data: Population-based reference data for the EORTC QLQ C–0. European Journal of Cancer, 37, 1331–334.
Ganz, P. A. (2002). What outcomes matter to patients: A physician-researcher point of view. Medical Care, 40(6 Suppl. III), 11–9.
Gotay, C. C., & Muraoka, M. Y. (1998). Quality of life in long-term survivors of adult-onset cancers. Journal of the National Cancer Institute, 90, 656–67.
Group, Early Breast Cancer Trialists–Collaborative Group (EBCTCG). (2005). Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: An overview of the randomised trials. Lancet, 365, 1687–717.
Hahn, H. M., Yum, T. H., & Shin, Y. W. et al. (1986). A standardization study of the Beck Depression Inventory in Korea. Journal of the Korean Neuropsychiatric Association, 25, 487–02.
Hanson, F. M., Suman, V. J., & Rummans, T. A. et al. (2000). Physical, psychological and social well-being of women with breast cancer: The influence of disease phase. Psychooncology, 9, 221–31.
Hewitt, M., & Simone, J. V. (Eds.). (1999). Institute of Medicine Report: Ensuring quality cancer care–National Cancer Policy Board, Institute of Medicine Report and National Research Council. Washington, DC: National Academy Press. Institute of Medicine, Commission On Life Sciences National Research Council: Ensuring quality cancer care. Washington, DC: National Academy Press.
Hoffman, R. M., Hunt, W. C., Gilliland, F. D., Stephenson, R. A., & Potosky, A. L. (2003). Patient satisfaction with treatment decisions for clinically localized prostate carcinoma. Results from the Prostate Cancer Outcomes Study. Cancer, 97, 1653–662.
Hurny, C., Bernhard, J., & Coates, A. S. et al. (1997). Impact of adjuvant therapy on quality of life in women with node-positive operable breast cancer. International Breast Cancer Study Group. Lancet, 350, 298.
Katz, S. J., Lantz, P. M., & Janz, N. K. et al. (2005). Patient involvement in surgery treatment decisions for breast cancer. Journal of Clinical Oncology, 23, 5526–533.
Kramer, J. A., Curran, D., & Piccart, M. et al. (2000). Randomised trial of paclitaxel versus doxorubicin as first-line chemotherapy for advanced breast cancer: Quality of life evaluation using the EORTC QLQ-C30 and the Rotterdam symptom checklist. European Journal of Cancer, 36, 1488–497.
Lantz, P. M., Janz, N. K., & Fagerlin, A. et al. (2005). Satisfaction with surgery outcomes and the decision process in a population-based sample of women with breast cancer. Health Services Research, 40, 745–67.
Liang, W., Burnett, C. B., & Rowland, J. H. et al. (2002). Communication between physicians and older women with localized breast cancer: Implications for treatment and patient satisfaction. Journal of Clinical Oncology, 20, 1008–016.
Lipscomb, J., Gotay, C. C., & Snyder, C. (Eds.). (2005). Outcomes assessment in cancer: Measures, methods, and applications. Cambridge, England: Cambridge University Press.
Mandelblatt, J., Armetta, C., Yabroff, K. R., Liang, W., & Lawrence, W. (2004). Descriptive review of the literature on breast cancer outcomes: 1990 through 2000. Journal of the National Cancer Institute. Monographs, 33, 8–4.
Mendoza, T. R., Wang, X. S., & Cleeland, C. S. et al. (1999). The rapid assessment of fatigue severity in cancer patients: Use of the Brief Fatigue Inventory. Cancer, 85, 1186–196.
Northouse, L. L., Mood, D., & Kershaw, T. et al. (2002). Quality of life of women with recurrent breast cancer and their family members. Journal of Clinical Oncology, 20, 4050–064.
Oh, S., Heflin, L., Meyerowitz, B. E., Desmond, K. A., Rowland, J. H., & Ganz, P. A. (2004). Quality of life of breast cancer survivors after a recurrence: A follow-up study. Breast Cancer Research Treatment, 87, 45–7.
Okamura, H., Watanabe, T., & Narabayashi, M. et al. (2000). Psychological distress following first recurrence of disease in patients with breast cancer: Prevalence and risk factors. Breast Cancer Research Treatment, 6, 131–37.
Sainsbury, R., Johnston, C., & Haward, B. (1999). Effect on survival of delays in referral of patients with breast-cancer symptoms: A retrospective analysis. Lancet, 353, 1132–135.
Santiago, R. J., Wu, L., & Harris, E. et al. (2004). Fifteen-year results of breast conserving surgery and definitive irradiation for Stage I and II breast carcinoma: The University of Pennsylvania experience. International Journal of Radiation Oncology, Biology, Physics, 58, 233–40.
Spencer, S. M., Lehman, J. M., & Wynings, C. et al. (1999). Concerns about breast cancer and relations to psychosocial well-being in a multiethnic sample of early-stage patients. Health Psychology, 18, 159–68.
Wennberg, J. E. (2002). Unwarranted variations in health care delivery: Implications for academic medical centres. BMJ, 325, 961–64.
Young, K. E., & White, C. A. (2006). The prevalence and moderators of fatigue in people who have been successfully treated for cancer. Journal of Psychosomatic Research, 60, 29–8.
Yun, Y. H., Bae, S. H., & Kang, I. O. et al. (2004). Cross-cultural application of the Korean version of the European Organization for Research and Treatment of Cancer (EORTC) Breast-Cancer-Specific Quality of Life Questionnaire (EORTC QLQ-BR23). Support Care Cancer, 12, 441–45.
Yun, Y. H., Wang, X. S., & Lee, J. S. et al. (2005). Validation study of the korean version of the brief fatigue inventory. Journal of Pain and Symptom Management, 29, 165–72.
Acknowledgment
This work was supported by National Cancer Center Grant 04101502.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Lee, M.K., Son, B.H., Hwang, S.Y. et al. Factors affecting health-related quality of life in women with recurrent breast cancer in Korea. Qual Life Res 16, 559–569 (2007). https://doi.org/10.1007/s11136-006-9144-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11136-006-9144-6